This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Browse Topics

Pricing & Contracting

Strategies to position your product and value proposition effectively with government and commercial payers in a complex and competitive marketplace.

Articles & Video

Showing 5 of 5 articles & video

Webcast: The State of National Healthcare Policy and Pricing 2023

Can payment models for gene therapies evolve fast enough to keep up?

Gene therapy is revolutionizing healthcare, but can we revolutionize payment models in time to keep up?

"There is always something interesting behind a state's motivation to control prescription drug costs" - Q&A with Porzio Life Sciences

Jennifer A. Romanski, JD, Vice President and Sara R. Simon, JD, Compliance Associate at Porzio Life Sciences discuss interesting legislation coming related to State Price Transparency in this exclusive interview.

Patient-Centric

What does it mean to be patient centered in health economics?

As the movement towards more patient-centered health care gains momentum, how does health economics sit at this intersection between cost-effective care and patient-centered care?

Pricing & Reimbursement US 2020

Whether a drug product is covered, and at what price, is determined by each payer’s coverage, coding, and payment criteria for health insurance plans. The largest government-funded
programs are Medicare and Medicaid, under which plans are subject to detailed requirements set forth by statute or regulation.

Why gene therapy lotteries are good for patients, providers, and manufacturers

Jeremy Schafer, PharmD, MBA argues how drug lotteries like Novartis' new program could mean a fairer and more beneficial system for all.

HCEI and PIE: Is it time for pharma to be proactive in the argument over cost effectiveness?

How can drug manufacturers embracing the FDA's new HCEI and PIE guidance to engage payer customers early? Jeremy Schafer, PharmD, MBA, SVP, Precision for Value explores.